Is MVIS a Buy or a Sell? The Bull and Bear Case (2026)

That depends on which case you find more convincing, and both are on this page. The bull case rests on Industrial and defense pivot, with q1 2026 revenue at ~$0.9M. The bear case rests on the dominant risk is that revenue remains minimal relative to a large and continuing cash burn, so MicroVision depends on dilution through its at-the-market equity program and on senior secured convertible notes to stay funded, and analysts have flagged roughly 12 months of runway with a balance sheet that screens as financially distressed. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. The dominant risk is that revenue remains minimal relative to a large and continuing cash burn, so MicroVision depends on dilution through its at-the-market equity program and on senior secured convertible notes to stay funded, and analysts have flagged roughly 12 months of runway with a balance sheet that screens as financially distressed. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. Walnut is not an investment adviser.

Industrial and defense pivot. MicroVision has shifted emphasis from waiting on long-dated automotive contracts toward nearer-term industrial and security and defense demand.

The dominant risk is that revenue remains minimal relative to a large and continuing cash burn, so MicroVision depends on dilution through its at-the-market equity program and on senior secured convertible notes to stay funded, and analysts have flagged roughly 12 months of runway with a balance sheet that screens as financially distressed. The lidar market is crowded and competitive, with rivals including Hesai, Ouster, Innoviz, Aeva, and AEye, some better capitalized or already profitable. Automotive and defense sales cycles are long and lumpy, execution against the 2026 revenue ramp is unproven, and the stock trades with high volatility and speculative, retail-driven swings that can decouple from fundamentals.

MicroVision is a Redmond, Washington technology company that develops lidar and laser beam-scanning sensors.

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Industrial and defense pivot) stalling in the reported numbers rather than in the narrative, the risk above (the dominant risk is that revenue remains minimal relative to a large and continuing cash burn, so MicroVision depends on dilution through its at-the-market equity program and on senior secured convertible notes to stay funded, and analysts have flagged roughly 12 months of runway with a balance sheet that screens as financially distressed) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

That depends entirely on your goals and risk tolerance, and this is not a recommendation. The bull case is that MicroVision can scale industrial and defense lidar orders and win automotive programs, hitting its 2026 revenue guidance. The bear case is minimal revenue (~$0.9M in Q1 2026), large losses, heavy dilution, roughly 12 months of runway, and tough competition. MVIS is a speculative, volatile stock.

MicroVision develops lidar and laser beam-scanning sensors that measure distance and map surroundings. Its IRIS long-range sensors target automotive ADAS and autonomous driving, while its MOVIA L short-range sensors target industrial uses like mining and trucking plus security and defense applications such as drones and perimeter sensing. It also licenses an extensive lidar and laser-scanning patent portfolio.

No. MicroVision is not profitable and has a long history of losses. In Q1 2026 it reported revenue of about $0.9 million against a net loss of roughly $25.3 million, and trailing-twelve-month losses were around $91.5 million on roughly $1.55 million of revenue. The company funds its cash burn through equity sales and convertible notes.